Biotech News
Glox Therapeutics Receives Share of £3M CF AMR Syndicate Fund to Combat Lung Infections
Glox Therapeutics, a company specialising in precision antibiotic therapies, has secured up to £500,000 in funding from the Collaborative Discovery Programme (CDP). The CDP, launched by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate with backing from the medical research
22 January 2025
Stay ahead of trends and best practices
